pamidronate disodium 60mg/4ml solution for infusion ampoules
a a h pharmaceuticals ltd - pamidronate disodium - solution for infusion - 15mg/1ml
pamidronate disodium 60mg/10ml solution for infusion vials
a a h pharmaceuticals ltd - pamidronate disodium - solution for infusion - 6mg/1ml
pamidronate disodium 90mg/6ml solution for infusion ampoules
a a h pharmaceuticals ltd - pamidronate disodium - solution for infusion - 15mg/1ml
pamidronate disodium 90mg/10ml solution for infusion vials
a a h pharmaceuticals ltd - pamidronate disodium - solution for infusion - 9mg/1ml
pamidronate disodium 15mg/1ml solution for infusion ampoules
a a h pharmaceuticals ltd - pamidronate disodium - solution for infusion - 15mg/1ml
pamidronate disodium vial 9 mg/ml
مستودع البتراء للمواد الطبية - petra drug store - pamidronate disodium 9 mg/ml - 9 mg/ml
risedronate sodium- risedronate sodium tablet, film coated
mylan pharmaceuticals inc. - risedronate sodium (unii: ofg5exg60l) (risedronic acid - unii:km2z91756z) - risedronate sodium 5 mg - risedronate sodium tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women. in postmenopausal women with osteoporosis, risedronate reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [see clinical studies (14.1, 14.2) ]. risedronate sodium tablets are indicated for treatment to increase bone mass in men with osteoporosis. risedronate sodium tablets are indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment (daily dosage of greater than or equal to 7.5 mg of prednisone or equivalent) for chronic diseases. patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin d. risedronate sodium tablets are indicated for treatment of paget’s disease of bone in men and women. the optimal duration of use has not been determined. the safety and effectiveness of risedronate
pamidronate disodium
neomed technology ltd - pamidronate disodium - concentrate for soln for inf - 3mg/ml mg/ml
pamidronate disodium
neomed technology ltd - pamidronate disodium - concentrate for soln for inf - 9mg/ml mg/ml
pamidronate eg 3 mg/ml inf. sol. (conc.) i.v. vial
eg sa-nv - disodium pamidronate 3 mg/ml - eq. pamidronic acid 2,527 mg/ml - concentrate for solution for infusion - 3 mg/ml - pamidronate disodium 3 mg/ml - pamidronic acid